Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.01 (-1.10%)
Close on Nov 18, 2026Market cap $34.29MP/E –Yield –
Serina Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Serina Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$21.20M. For fiscal 2025 it was -$18.01M. The highest annual figure on record is -$2.98M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.01M | – |
| FY2024 | Dec 31, 2024 | -$17.16M | – |
| FY2023 | Dec 31, 2023 | -$2.98M | – |
| FY2020 | Dec 31, 2020 | -$7.84M | – |
| FY2019 | Dec 31, 2019 | -$10.80M | – |
| FY2018 | Dec 31, 2018 | -$8.02M | – |
| FY2017 | Dec 31, 2017 | -$6.29M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.71M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.59M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.03M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.86M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.32M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.59M | -9107.8% |
| Q3 FY2024 | Sep 30, 2024 | -$2.97M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.01M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.59M | – |
| Q4 FY2023 | Dec 31, 2023 | $51.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.14M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.90M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.07M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.71M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.61M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.87M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.62M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.05M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.79M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.17M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.01M | – |
See a number that looks wrong?